Importantly, blockade of PD-L1/PD1 signals by anti-PD1 Abs activates TAMs, leading to production of TAM-activating factors such as sCD163 and chemokines in the serum of melanoma patients [24,25,26,27,28]. The gene discussed is CD163; the disease is melanoma.